Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 15, 2019 - Issue 11
Submit an article Journal homepage
1,034
Views
10
CrossRef citations to date
0
Altmetric
Research Paper

Economic burden and associated factors of measles patients in Zhejiang Province, China

Xuan DengDepartment of Immunization Program , Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, PR ChinaORCID Iconhttps://orcid.org/0000-0002-7299-6527View further author information
ORCID Icon,
Hanqing HeDepartment of Immunization Program , Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, PR ChinaCorrespondence[email protected]
View further author information
,
Yang ZhouDepartment of Immunization Program , Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, PR ChinaView further author information
,
Shuyun XieDepartment of Immunization Program , Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, PR ChinaView further author information
,
Ya FangState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen, PR ChinaView further author information
,
Yanbing ZengState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen, PR ChinaView further author information
,
Rui YanDepartment of Immunization Program , Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, PR ChinaView further author information
,
Xuewen TangDepartment of Immunization Program , Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, PR ChinaView further author information
&
Jian FuDepartment of Immunization Program , Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, PR ChinaView further author information
 show all
Pages 2571-2577 | Received 21 Nov 2018, Accepted 13 Mar 2019, Published online: 22 Apr 2019

References

  • WHO. Measles. 2019 [accessed 11 April 2019]. http://www.who.int/mediacentre/factsheets/fs286/en/
  • He H, Chen E, Chen H, Wang Z, Li Q, Yan R, Guo J, Zhou Y, Pan J, Xie S, et al. Similar immunogenicity of measles-mumps-rubella (MMR) vaccine administrated at 8 months versus 12 months age in children. Vaccine. 2014;32(31):4001–05. doi:10.1016/j.vaccine.2014.04.044.
  • Roggendorf H, Santibanez S, Mankertz A, Van Treeck U, Roggendorf M. Two consecutive measles outbreaks with genotypes D8 and D4 in two mainly unvaccinated communities in Germany. Med Micro Immunol. 2012;201(3):349–55. doi:10.1007/s00430-012-0240-7.
  • Duraisamy R, Rota PA, Palani G, Elango V, Sambasivam M, Lowe L, Lopareva E, Ramamurty N. Molecular characterization of wild-type measles viruses in Tamil Nadu, India, during 2005–2006: relationship of genotype D8 strains from Tamil Nadu to global strains. J Med Virol. 2012;84(2):348–57.
  • Yang W, Wen L, Li SL, Chen K, Zhang WY, Shaman J. Geospatial characteristics of measles transmission in China during 2005-2014. PLoS Comput Biol. 2017;13(4):e1005474. doi:10.1371/journal.pcbi.1005731.
  • Zhang J, Ji Y, Cui J, Chen W, Li A, Cheng M. Imported measles virus genotype D8 during 2013 in Beijing, China. Chin J Viral Dis. 2014;4:272–76.
  • Gao J, Shen B, Xiong J, Lu Y, Jiang Q. The measles epidemic trend over the past 30 years in a central district in Shanghai, China. PLoS One. 2017;12(6):e0179470. doi:10.1371/journal.pone.0179470.
  • WHO. World health statistics 2016: monitoring health for the SDGs, sustainable development goals. Geneva, Switzerland. 2016.
  • Orenstein WA, Hinman AR. Measles: the burden of preventable deaths. Lancet. 2012;379(9832):2130–31. doi:10.1016/S0140-6736(12)60638-2.
  • Bester JC. Measles and measles vaccination: a review. JAMA Pediatr. 2016;170(12):1209–15. doi:10.1001/jamapediatrics.2015.3886.
  • Colzani E, McDonald SA, Carrillo-Santisteve P, Busana MC, Lopalco P, Cassini A. Impact of measles national vaccination coverage on burden of measles across 29 member states of the European Union and European economic area, 2006–2011. Vaccine. 2014;32:1814–19.
  • Guo S, Liang X, Zuo S. Economic burden on measles, rubella, and mumps‘ cases in China in 2004. Chin J Vaccines Immunization. 2008;14:32–36.
  • Pelletier L, Chung P, Duclos P, Manga P, Scott J. A benefit–cost analysis of two-dose measles immunization in Canada. Vaccine. 1998;16(9–10):989–96. doi:10.1016/S0264-410X(97)00281-8.
  • Plass D, Mangen MJ, Kraemer A, Pinheiro P, Gilsdorf A Krause G, Gibbons CL, Van Lier, A, McDonald, SA, et al. The disease burden of hepatitis B, influenza, measles and salmonellosis in Germany: first results of the burden of communicable diseases in Europe Study. Epidemiol Infect. 2014;142(10):2024–35. doi:10.1017/S0950268814000211.
  • Wichmann O, Siedler A, Sagebiel D, Hellenbrand W, Santibanez S, Mankertz A, Vogt G, Treeck UV, Krause G. Further efforts needed to achieve measles elimination in Germany: results of an outbreak investigation. Bull World Health Organ. 2009;87(2):108–15. doi:10.2471/BLT.07.050187.
  • Ortega-Sanchez IR, Vijayaraghavan M, Barskey AE, Wallace GS. The economic burden of sixteen measles outbreaks on United States public health departments in 2011. Vaccine. 2014;32(11):1311–17. doi:10.1016/j.vaccine.2013.10.012.
  • Ghebrehewet S, Thorrington D, Farmer S, Kearney J, Blissett D, McLeod H, Keenan A. The economic cost of measles: healthcare, public health and societal costs of the 2012-13 outbreak in Merseyside, UK. Vaccine. 2016;34(15):1823–31. doi:10.1016/j.vaccine.2016.10.045.
  • Filia A, Brenna A, Pana A, Cavallaro GM, Massari M, Degli Atti MLC. Health burden and economic impact of measles-related hospitalizations in Italy in 2002–2003. BMC Public Health. 2007;7:169. doi:10.1186/1471-2458-7-169.
  • Zwanziger J, Szilagyi PG, Kaul P. Evaluating the benefits of increasing measles immunization rates. Health Serv Res. 2001;36:885–909.
  • Perry RT, Halsey NA. The clinical significance of measles: a review. J Infect Dis. 2004;189(Suppll):S4–16. doi:10.1086/377712.
  • Dyer MT, Goldsmith KA, Sharples LS, Buxton MJ. A review of health utilities using the EQ-5D in studies of cardiovascular disease. Health Qual Life Outcomes. 2010;8:13. doi:10.1186/1477-7525-8-13.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.